1. Home
  2. HITI vs MDWD Comparison

HITI vs MDWD Comparison

Compare HITI & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo High Tide Inc.

HITI

High Tide Inc.

HOLD

Current Price

$2.80

Market Cap

257.8M

Sector

N/A

ML Signal

HOLD

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$18.74

Market Cap

238.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HITI
MDWD
Founded
2009
2000
Country
Canada
Israel
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
257.8M
238.5M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
HITI
MDWD
Price
$2.80
$18.74
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$6.13
$37.50
AVG Volume (30 Days)
767.2K
90.0K
Earning Date
01-28-2026
11-20-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$410,600,094.00
$20,932,000.00
Revenue This Year
$14.07
$15.89
Revenue Next Year
$29.67
$25.33
P/E Ratio
N/A
N/A
Revenue Growth
11.18
6.15
52 Week Low
$1.64
$14.14
52 Week High
$4.06
$22.51

Technical Indicators

Market Signals
Indicator
HITI
MDWD
Relative Strength Index (RSI) 52.10 55.59
Support Level $2.65 $18.55
Resistance Level $3.01 $19.30
Average True Range (ATR) 0.17 0.57
MACD 0.04 0.03
Stochastic Oscillator 61.41 62.91

Price Performance

Historical Comparison
HITI
MDWD

About HITI High Tide Inc.

High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, Famous Brandz, and others. The company's reportable operating segments are; Bricks and mortar which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada followed by the United States of America, and other international markets.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: